This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931, AJP Lung Cellular and Molecular Physiology, September 2016, American Physiological Society,
DOI: 10.1152/ajplung.00298.2016.
You can read the full text:
The following have contributed to this page
